Buy JWH-019 Powder online

Buy JWH-019 Powder online, JWH-019 is a synthetic cannabinoid, belonging to a large family of compounds that interact with the endocannabinoid system in the human body. It was developed as part of the research conducted by Dr. John W. Huffman and his team to explore the effects of cannabinoids and to study the CB1 and CB2 receptors, which play significant roles in regulating a variety of physiological and neurological processes.

Chemical Structure and Properties | Buy JWH-019 Powder online

JWH-019 is classified as an indole-based cannabinoid, a category characterized by the presence of an indole core in their molecular structure.

The structure of JWH-019 is similar to other compounds in the JWH series, such as JWH-018, with the major difference being the length of the alkyl chain. In JWH-019, this alkyl chain is a hexyl group (six carbon atoms), compared to the pentyl chain in JWH-018. This small structural variation can significantly alter the compound’s interaction with cannabinoid receptors, which influences its potency and effects.

JWH-019 has been synthesized primarily for research purposes and was not initially intended for human consumption. However, like many synthetic cannabinoids, it has been used in recreational contexts. The compound exhibits agonistic behavior toward the CB1 and CB2 cannabinoid receptors, mimicking the effects of delta-9-tetrahydrocannabinol (THC), the primary psychoactive constituent of cannabis.

Mechanism of Action

JWH-019 interacts with the cannabinoid receptors CB1 and CB2, which are distributed throughout the body but are particularly concentrated in the brain and immune system, respectively. These receptors are part of the endocannabinoid system, which is involved in a range of processes such as mood regulation, appetite control, pain sensation, and immune response.

• CB1 receptors: These are primarily located in the central nervous system and are responsible for the psychoactive effects of cannabinoids. Activation of these receptors by compounds like JWH-019 can lead to changes in perception, mood, and cognition.
• CB2 receptors: Found mostly in peripheral tissues, especially those related to the immune system, the activation of CB2 receptors typically modulates immune response and inflammation.

The agonistic action of JWH-019 at these receptors makes it functionally similar to natural cannabinoids, though it often produces effects that are more intense and long-lasting. Synthetic cannabinoids like JWH-019 are known to have higher affinities for these receptors compared to THC, making them potent agonists.

Potency and Receptor Affinity

In terms of receptor affinity, JWH-019 is known to have a strong binding affinity for both CB1 and CB2 receptors, although the affinity for CB1 is higher, which is associated with its psychoactive properties. Studies on the potency of JWH-019 indicate that it is generally considered less potent than its close analogue JWH-018 but still significantly stronger than THC. The difference in potency between these synthetic cannabinoids can be attributed to the length of the alkyl chain, which affects how well the compound fits into the receptor’s binding site.

The modification of the alkyl chain from five to six carbons in JWH-019 compared to JWH-018 reduces its binding affinity somewhat, making JWH-019 a slightly weaker agonist. Despite this, it still maintains substantial efficacy, activating the same pathways as natural cannabinoids like THC.

Chemical Synthesis

The synthesis of JWH-019, like other synthetic cannabinoids, involves the condensation of 1-hexylindole with 1-naphthoyl chloride. This reaction yields the naphthoylindole structure, which forms the core of the compound. The hexyl group attached to the indole nitrogen is responsible for the compound’s interaction with cannabinoid receptors.

The chemical synthesis of JWH-019 is a multi-step process that requires specialized knowledge of organic chemistry and is typically carried out in research laboratories. Each step in the synthesis must be carefully controlled to ensure the correct structure is obtained, as small changes in the molecular structure can significantly affect the compound’s activity.

Pharmacokinetics

The pharmacokinetics of JWH-019, while not as extensively studied as natural cannabinoids, can be inferred based on its similarity to other synthetic cannabinoids. Once consumed, JWH-019 is absorbed and distributed through the bloodstream, where it crosses the blood-brain barrier and binds to cannabinoid receptors. Its lipophilic nature (tendency to dissolve in fats) allows it to be absorbed into fatty tissues, leading to prolonged effects.

Metabolism of JWH-019 primarily occurs in the liver, where it is broken down by cytochrome P450 enzymes into various metabolites. These metabolites are then excreted from the body via the kidneys and urine. The exact metabolic pathways and the potential for active metabolites are still subjects of ongoing research, but synthetic cannabinoids are often metabolized in a manner similar to THC.

The elimination half-life of JWH-019 is likely to be longer than that of THC, given its high lipophilicity and binding affinity for cannabinoid receptors. This means that the compound could remain active in the body for an extended period after ingestion.

Comparative Analysis with Other Cannabinoids

It belongs to a broader class of synthetic cannabinoids developed for research into the endocannabinoid system. It is similar to other JWH-series compounds like JWH-018 and JWH-073, which also interact with CB1 and CB2 receptors. The key difference between these compounds lies in the length and structure of the alkyl chain attached to the indole group, which influences their potency, receptor affinity, and duration of action.

Compared to natural cannabinoids like THC, synthetic cannabinoids like JWH-019 tend to have higher potency and longer-lasting effects due to their stronger binding affinities. This makes them particularly useful in research but also more unpredictable in other contexts.

It is a synthetic cannabinoid developed for research purposes to better understand the interactions between cannabinoids and their respective receptors in the endocannabinoid system. Its chemical structure is based on the indole core, with a naphthoyl group and a hexyl chain that differentiate it from other similar compounds. As a potent agonist for CB1 and CB2 receptors, JWH-019 is a valuable tool in exploring the pharmacology of cannabinoids, though its potency and synthetic nature differentiate it from naturally occurring cannabinoids like THC.

Its unique properties, including strong receptor affinity, high potency, and distinct metabolic pathways, make it a subject of interest in the field of cannabinoid research. However, it also highlights the broader complexity of synthetic cannabinoids and their various effects on the human body.